KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Interest Expenses (2016 - 2025)

West Pharmaceutical Services' Interest Expenses history spans 17 years, with the latest figure at -$200000.0 for Q4 2025.

  • For Q4 2025, Interest Expenses rose 75.0% year-over-year to -$200000.0; the TTM value through Dec 2025 reached $500000.0, down 83.33%, while the annual FY2025 figure was $500000.0, 83.33% down from the prior year.
  • Interest Expenses for Q4 2025 was -$200000.0 at West Pharmaceutical Services, down from $200000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $2.9 million in Q3 2023 and bottomed at -$800000.0 in Q4 2024.
  • The 5-year median for Interest Expenses is $1.8 million (2021), against an average of $1.4 million.
  • The largest annual shift saw Interest Expenses crashed 166.67% in 2024 before it surged 75.0% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $2.6 million in 2021, then plummeted by 34.62% to $1.7 million in 2022, then fell by 29.41% to $1.2 million in 2023, then crashed by 166.67% to -$800000.0 in 2024, then soared by 75.0% to -$200000.0 in 2025.
  • Per Business Quant, the three most recent readings for WST's Interest Expenses are -$200000.0 (Q4 2025), $200000.0 (Q3 2025), and $100000.0 (Q2 2025).